ESMO 2024 Highlights: Presenter Vignette – Ewa Kalinka

Dr. Ewa Kalinka

Ewa Kalinka

MD, PhD

Polish Mother’s Memorial Hospital - Research Institute

Abstract# 1786O

BMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with carboplatin + etoposide + nivolumab (CE/NIVO) as first-line (1L) therapy in extensive-stage small cell lung cancer (ES-SCLC): interim analysis (IA) of a randomized phase 2 study